A prospective, iterative, adaptive trial of carfilzomib‐based desensitization
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Transplantation"
DOI: 10.1111/ajt.15613
Abstract: Proteasome inhibitor–based strategies hold promise in transplant but have yielded varying results. Carfilzomib, a second‐generation proteasome inhibitor, may possess advantages over bortezomib, the first‐generation proteasome inhibitors. The purpose of this study was to evaluate the… read more here.
Keywords: adaptive trial; iterative adaptive; based desensitization; desensitization ... See more keywords